Pressrum

Nyheter och pressmeddelanden

Här kan du läsa nyheter och pressmeddelanden om Paindrainer. Vi lägger även ut lediga tjänster, så håll ögonen öppna!

No items found.
3/4/2025

Paindrainer AB raises 9.5 million in an oversubscribed share issue

LUND, SWEDEN – Paindrainer AB announces a successfully completed share issue of 9.5 MSEK, supported by Almi Invest, Fredrik Sjödin via Tramontane Invest, ReThink Capital and existing shareholders.

Läs mer
Read more
No items found.
9/23/2024

Paindrainer AB partners with Complete Care Partners LLC to accelerate the commercial role out in U.S. and transform chronic pain management

MEDICON VILLAGE, LUND, SWEDEN – Paindrainer AB announces that the company has signed a partnership agreement allowing access to several thousand patients with chronic conditions managed by Complete Care Partner (CCP). This is made possible since Complete Care Partners (CCP) will access Paindrainer PD1, the company’s complete solution for Remote Therapeutic Monitoring (RTM), in their services reaching patients in over 70 healthcare providers.

Läs mer
Read more
No items found.
6/26/2024

Paindrainer AB shortlisted for prominent Life Science Awards at NLSDays 2024

MEDICON VILLAGE, LUND, SWEDEN – Paindrainer AB, is proud to be selected as one of few companies shortlisted for the esteemed Nordic Star pitch competition. This prestigious pitch competition will take place at Nordic Life Science Days (NLSDays) in Malmö, Sweden on September 18-19, 2024.

Läs mer
Read more
No items found.
6/24/2024

Paindrainer AB is selected to the prestigious Prevent2Care Program upheld by Ramsay Santé Foundation and Pfizer Innovation France

MEDICON VILLAGE, LUND, SWEDEN – Paindrainer AB, is pleased to announce its selection for the prestigious Prevent2Care Lab Program. This program provides invaluable access to the extensive business expertise of the Ramsay Santé Group, a European leader in the private hospitalization, embodying their commitment to innovation.

Läs mer
Read more
No items found.
5/14/2024

Paindrainer’s digital medical device approved for a clinical study investigating its effect on brain activities

The Paindrainer digital medical device will be used to investigate how chronic pain is processed in the brain using Cleveland Clinic’s established brain scanning technology, as well as evaluate the correlation between users' logged data and objectively measured real world data through wearables. The study will be held at Cleveland Clinic in collaboration with Lund University.

Läs mer
Read more
No items found.
4/16/2024

Paindrainer AB to be granted patent for its unique patient-centric concept for chronic pain management

MEDICON VILLAGE, LUND, SWEDEN – Paindrainer AB, a pioneer in the field of digital healthcare technology, is pleased to announce that the European Patent Office (EPO) has granted a patent for its unique proprietary platform for 360° patient-centricity, chronic pain management, powered by an artificial neural network.

Läs mer
Read more
No items found.
3/28/2024

Paindrainer AB ingår nytt partnerskap med ansedda Bragée Kliniker för att förbättra distans patientvården genom patientcentrerat digitalt smärthanteringsprogram

MEDICON VILLAGE, LUND, SVERIGE - I ett nytt partnerskap kommer Paindrainer AB, en pionjär inom digital hälsovård, och de väletablerade Bragée Kliniker, att genomföra en kommersiell pilot som syftar till att stärka rehabilitering- och behandlingsprogram för patienter med långvarig smärta.

Läs mer
No items found.
2/21/2024

Paindrainer AB lanserar en banbrytande plattform för distansmonitorering (RTM) för innovativ hantering av kronisk smärta

MEDICON VILLAGE, LUND – Paindrainer AB, en föregångare inom digitala medicintekniska lösningar för kronisk smärta, är glada att presentera Paindrainer Care Portal. Tillsammans med mobilapplikationen Paindrainer PD1 erbjuder den en komplett lösning för vårdgivare att distansmonitorera sina patienters framsteg och förbättra deras livskvalitet.

Läs mer
Kom igång

Ladda ner appen och börja idag!

Vill du förstå hur dina aktiviteter påverkar smärtnivån och förbättra din livskvalitet? Du får 14 dagar provperiod. 100% av deltagarna i den kliniska studien på Weill Cornell Medicine i New York angav bättre förståelse hur deras aktiviteter påverkar deras smärtnivå.

Ta en rundtur
Ladda ner
Screenshot från appens första sida.